Taiyen Biotech CoTPE:1737 83 PEG Ratio is 54.98 as of Jul. 11, 2026, which is 1475% above its 10-year median of 3.49. GuruFocus rates TPE:1737 with a GF Score™ of 83/100 and a GF Value™ of NT$32.08 (Fairly Valued). The stock has 1 warning sign investors should review. Among 789 Consumer Packaged Goods companies, Taiyen Biotech Co ranks worse than 98.1% on this metric.
* The 5-Year EBITDA Growth Rate is the 5-year average EBITDA per share growth rate. While the denominator is a percentage, we use the whole number as opposed to the decimal form for the calculation. For example, 5% would be shown as 5 as opposed to 0.05. If it's smaller than or equal to 0, then the PEG Ratio is not calculated.
The historical rank and industry rank for Taiyen Biotech Co's PEG Ratio or its related term are showing as below:
TPE:1737'
s PEG Ratio Range Over the Past 10 Years
Min: 0.47 Med: 3.49 Max: 55.23
Current: 54.97
During the past 13 years, Taiyen Biotech Co's highest PEG Ratio was 55.23. The lowest was 0.47. And the median was 3.49.
TPE:1737's PEG Ratio is ranked worse than 98.1% of 789
companies
in the Consumer Packaged Goods industry
Industry Median: 1.3
vs TPE:1737: 54.97
Peter Lynch thinks a company with a P/E ratio equal to its growth rate is fairly valued.
Taiyen Biotech Co (TPE:1737) PEG Ratio Explanation
To compare stocks with different growth rates, Peter Lynch invented a ratio called PEG Ratio. PEG Ratio is defined as the P/E ratio divided by the growth ratio. He thinks a company with a P/E ratio equal to its growth rate is fairly valued. Still he said he would rather buy a company growing 20% a year with a P/E of 20, instead of a company growing 10% a year with a P/E of 10.
Taiyen Biotech Co PEG Ratio Related Terms
Taiyen Biotech Co PEG Ratio Historical Data
* Premium members only.
The historical data trend for Taiyen Biotech Co's PEG Ratio can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Household & Personal Products subindustry, Taiyen Biotech Co's PEG Ratio, along with its competitors' market caps and PEG Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Taiyen Biotech Co PEG Ratio vs Consumer Packaged Goods Industry
For the Consumer Packaged Goods industry and Consumer Defensive sector, Taiyen Biotech Co's PEG Ratio distribution charts can be found below:
* The bar in red indicates where Taiyen Biotech Co's PEG Ratio falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
* Note: The 5-Year EBITDA Growth Rate is the 5-year average EBITDA per share growth rate. While the denominator is a percentage, we use the whole number as opposed to the decimal form for the calculation. For example, 5% would be shown as 5 as opposed to 0.05. If it's smaller than or equal to 0, then the PEG Ratio is not calculated.
Taiyen Biotech Co (TPE:1737) has a PEG Ratio of 54.98 as of Jul. 11, 2026. Price-earnings to growth ratio is the ratio of price-earnings to a company's earnings growth rate. View historical data on Taiyen Biotech Co and its competitors. This is 1475% above median its historical median of 3.49. Over the past decade, Taiyen Biotech Co's PEG Ratio has ranged from 0.47 to 55.23. According to the industry distribution chart, Taiyen Biotech Co ranks #774 out of 789 companies in the Consumer Packaged Goods industry, placing it in the top 98.1%.
Is Taiyen Biotech Co's PEG Ratio too high?
Taiyen Biotech Co's current PEG Ratio of 54.98 is 1475% above median its 10-year median of 3.49. Over the past 10 years, this metric has ranged from a low of 0.47 to a high of 55.23. The Consumer Packaged Goods industry median PEG Ratio is 1.30. Taiyen Biotech Co's value of 54.98 is 4129.2% above this industry median. Based on the distribution chart, Taiyen Biotech Co ranks #774 out of 789 companies in the Consumer Packaged Goods industry, which is in the bottom quartile relative to peers. Overall, Taiyen Biotech Co has a GF Score™ of 83/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Taiyen Biotech Co's PEG Ratio compare to PG and CL?
According to the Consumer Packaged Goods industry distribution chart, Taiyen Biotech Co ranks #774 out of 789 companies for PEG Ratio. This places Taiyen Biotech Co in the lower half of its industry. The industry median PEG Ratio is 1.30. Taiyen Biotech Co's value of 54.98 is 4129.2% above this benchmark. Historically, Taiyen Biotech Co's own PEG Ratio has ranged from 0.47 to 55.23 over the past decade. While the company's 10-year median is 3.49 vs. the industry median of 1.30, Taiyen Biotech Co has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good PEG Ratio for a Consumer Packaged Goods company?
The median PEG Ratio among Consumer Packaged Goods companies is 1.30, based on 789 companies in the industry. Companies in the top quartile (top 25%) have a PEG Ratio significantly above this median, while those in the bottom quartile fall well below. However, PEG Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Taiyen Biotech Co's current PEG Ratio of 54.98 is 4129.2% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high PEG Ratio mean?
A high PEG Ratio can signal that a stock is expensive relative to its fundamentals. Price-earnings to growth ratio is the ratio of price-earnings to a company's earnings growth rate. View historical data on Taiyen Biotech Co and its competitors. For the Consumer Packaged Goods industry, the median PEG Ratio is 1.30 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Taiyen Biotech Co's current PEG Ratio is 54.98, which is 1475% above median its own 10-year median of 3.49. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Taiyen Biotech Co stock overvalued right now?
Based on GuruFocus' analysis, Taiyen Biotech Co (TPE:1737) is currently considered Fairly Valued. The stock's GF Value™ is NT$32.08, compared to a current price of NT$31.90 — trading 0.6% below its estimated fair value. The current PEG Ratio is 54.98, which is 1475% above median its 10-year median of 3.49 and 4129.2% above the Consumer Packaged Goods industry median of 1.30. Taiyen Biotech Co's overall GF Score™ is 83/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is PEG Ratio calculated?
PEG Ratio is calculated from a company's financial statements. For Taiyen Biotech Co (TPE:1737), the current PEG Ratio is 54.98 as of Jul. 11, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Taiyen Biotech Co (TPE:1737) Overvalued in 2026?
Based on GuruFocus' analysis, Taiyen Biotech Co stock appears to be undervalued.
The current stock price of NT$31.90 is trading 0.6% below its estimated GF Value™ of NT$32.08.
GuruFocus considers Taiyen Biotech Co to be Fairly Valued.
Key valuation signals for TPE:1737:
PEG Ratio: 54.98 (1475% above median its 10-year median of 3.49)
GF Value™: NT$32.08 vs. price of NT$31.90 (0.6% below fair value)
Industry Position: 4129.2% above the Consumer Packaged Goods median (#774 of 789)
No single metric tells the full story. See the TPE:1737 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Taiyen Biotech Co Ltd operates in personal care and home care products. Its product portfolio comprises beauty care products, health food, skin products, salt products and spices, bottled water, and medical supplies, among others. The group has four reportable segments; Salt products and packaged water department, Biotech cleaning and maintenance department, Construction and services department, and Other departments.. The Salt and Packaged Product Segment accounts for the bulk of revenue. Geographically it operates through the region of Taiwan; however, it also holds a presence in the international market.
83GF Score
Get the complete analysis for TPE:1737
PEG Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
TPE:1737 has been successfully added to your 
